HWM
XENE icon

HighMark Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History

HighMark Wealth Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Hold
23,000
– – 0.54% 26
2025
Q4 		$1.03M Sell
23,000
-3,100
-12% -$130K 0.42% 33
2025
Q3 		$1.05M Hold
26,100
– – 0.46% 30
2025
Q2 		$817K Buy
26,100
+20,000
+328% +$652K 0.4% 34
2025
Q1 		$205K Hold
6,100
– – 0.12% 55
2024
Q4 		$239K Buy
6,100
+1,100
+22% +$45.5K 0.14% 47
2024
Q3 		$197K Hold
5,000
– – 0.11% 65
2024
Q2 		$195K Hold
5,000
– – 0.12% 64
2024
Q1 		$215K Buy
+5,000
New +$230K 0.13% 57

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return